AMPK is reported to be overactivated in the brains of patients with neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis [31, 32]. Here, PRKAA1 is linked to amyotrophic lateral sclerosis.